Head-To-Head Review: Ingevity (NGVT) versus Its Peers

Ingevity (NYSE: NGVT) is one of 33 publicly-traded companies in the “Commodity Chemicals” industry, but how does it weigh in compared to its peers? We will compare Ingevity to related businesses based on the strength of its analyst recommendations, institutional ownership, valuation, risk, profitability, dividends and earnings.


This table compares Ingevity and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Ingevity 9.86% 58.14% 12.09%
Ingevity Competitors -29.50% 24.34% 5.63%

Insider & Institutional Ownership

91.4% of Ingevity shares are owned by institutional investors. Comparatively, 70.9% of shares of all “Commodity Chemicals” companies are owned by institutional investors. 0.1% of Ingevity shares are owned by insiders. Comparatively, 7.8% of shares of all “Commodity Chemicals” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Risk & Volatility

Ingevity has a beta of 1.78, suggesting that its stock price is 78% more volatile than the S&P 500. Comparatively, Ingevity’s peers have a beta of 1.13, suggesting that their average stock price is 13% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations for Ingevity and its peers, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ingevity 0 0 6 0 3.00
Ingevity Competitors 108 836 1231 36 2.54

Ingevity presently has a consensus target price of $76.00, indicating a potential upside of 0.70%. As a group, “Commodity Chemicals” companies have a potential downside of 0.55%. Given Ingevity’s stronger consensus rating and higher possible upside, analysts clearly believe Ingevity is more favorable than its peers.

Valuation and Earnings

This table compares Ingevity and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Ingevity $908.30 million $35.20 million 34.00
Ingevity Competitors $4.01 billion $340.26 million 131.95

Ingevity’s peers have higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.


Ingevity beats its peers on 8 of the 13 factors compared.

About Ingevity

Ingevity Corporation is a manufacturer of specialty chemicals and high performance carbon materials. The Company is also a manufacturer of activated carbon used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Company operates through two segments: Performance Materials and Performance Chemicals. The Performance Materials segment primarily produces automotive carbon products used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. The Performance Chemicals segment develops, manufactures and sells a range of specialty chemicals primarily derived from co-products of the Kraft pulping process. Its products are used in a range of applications, including asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, publication inks and automotive components that reduce gasoline vapor emissions.

Receive News & Ratings for Ingevity Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply